ORPH - Orphazyme A/S Unsponsored ADR

Healthcare - Sector
Coverage Rating Distribution Performance Price Targets & Ratings Chart

ORPH is currently covered by 1 analysts with average potential upside of $-0.97 (-12.03%) backed by 0 price targets and 1 ratings. Analyst's average stock valuation to be materialised ratio is 100% with an average time for price targets to be met of 75 days.

Most recent stock forecast was given by TAZEEN AHMAD from BAML on 30-Mar-2021.

Highest price target for ORPH is 7, Lowest price target is 7, average price target is 7.

Best performing analysts who are covering ORPH - Orphazyme A/S Unsponsored ADR:

Tazeen Ahmad

Currently, out of the existing stock ratings of ORPH - 1 which are a Buy (100%)

Analyst name


Current price target

Potential distance

Previous price target


Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score



$4.66 (1370.59%)


1 years 11 months 26 days ago

2/2 (100%)

$-0.97 (-12.03%)


Show more analysts

What is ORPH(Orphazyme A/S Unsponsored ADR) average time for price targets to be met?

On average it took 75 days on average for the stock forecasts to be realized with a an average price target met ratio 100

Which analyst has the current highest performing score on ORPH(Orphazyme A/S Unsponsored ADR) with a proven track record?